Analysis – Page 44 – Goldea Capital

Solar A/S: No. 9 2025 Solar signs agreement to acquire Sonepar in Norway

Written by Customer Service on October 22, 2025. Posted in Public Companies.

Today, Solar Norge AS has signed an agreement with Sonepar Sverige AB to acquire 100% of Sonepar Norge AS. The transaction values Sonepar Norge at DKK 315m on an Enterprise Value basis. The transaction is not expected to have an impact on the Solar Group results in 2025 except for the expected acquisition costs of DKK 5m. The transaction will be financed through a combination of 1/3 equity financing via an accelerated bookbuilding and 2/3 debt financing. CEO Jens Andersen says:“The combination of Solar and Sonepar in Norway will be transformative for our Norwegian business by creating economies of scale in addition to improving our physical distribution channels with a strong network of branches. The strong operational and commercial synergies between the companies are expected to unlock significant opportunities to develop the combined...

ALSTOM S.A: Eurostar chooses Alstom for 30 Avelia Horizon very high-speed trains

Written by Customer Service on October 22, 2025. Posted in Public Companies.

This optional tranche of the framework contract between SNCF Voyageurs and Alstom represents an amount of close to 1.4 billion euros. The new Avelia Horizon trains will be operated by Eurostar and will travel through the Channel Tunnel, a first for a double-deck high-speed train.22 October 2025 – The SNCF Voyageurs Board of Directors has approved an additional order for 30 new-generation Avelia Horizon very high-speed trains for close to 1.4 billion euros1, as well as options for up to 20 additional trains. First deliveries are scheduled for 2031. This order concerns the four-voltage version of this very high-speed train, which meets the needs of European traffic. The international trainsets will operate on the rail networks of five countries under the Eurostar banner: Germany, Belgium, France, the Netherlands and the United...

Ringkjøbing Landbobank’s quarterly report for the three quarters of 2025

Written by Customer Service on October 22, 2025. Posted in Earnings Releases And Operating Results.

Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeOther stakeholders 22 October 2025 Ringkjøbing Landbobank’s quarterly report for the three quarters of 2025 The bank’s board of directors and general management today approved the report for the first three quarters of 2025. The bank delivers core earnings of DKK 2,321 million and net profit of DKK 1,753 million in the first three quarters of the year. The net profit is equivalent to a 21% p.a. return on equity.Core earnings(DKK million) Q1-Q3 2025 Q1-Q3 2024 2024 2023 2022 2021Total core income 2,090 3,067 4,068 3,828 2,862 2,433Total expenses and depreciation 534 761 1,044 963 891 817Core earnings before impairment charges for loans 1,556 2,306 3,024 2,865 1,971 1,616Impairment charges for loans etc. +24 +2 +3 -1 -2 -68Core earnings 1,580 2,308 3,027 2,864 1,969 1,548Result...

Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline

Written by Customer Service on October 22, 2025. Posted in Mergers And Acquisitions.

Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a new standard of care in combination in first line unfit acute myeloid leukemia, an aggressive blood cancer affecting older adults Ipsen to acquire all issued and outstanding shares of ImCheck Therapeutics, for which ImCheck Therapeutics’ shareholders will be eligible to receive a closing purchase price of 350 million euros and downstream payments contingent upon achievement of regulatory and sales-based milestonesPARIS AND MARSEILLE, FRANCE, 22 October 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) and ImCheck Therapeutics today announced they have entered into a definitive share purchase agreement in which Ipsen will acquire all issued and...

Coop Pank unaudited financial results for Q3 2025

Written by Customer Service on October 22, 2025. Posted in Earnings Releases And Operating Results.

By the end of the Q3 2025, Coop Pank had 222,000 customers, increased by 4,000 customers in the quarter (+2%) and by 20,000 in the year (+10%). The bank had 105,400 active customers, increased by 1,800 (+2%) in the quarter and by 10,000 (+10%) in the year. In Q3 2025, volume of deposits in Coop Pank increased by 105 million euros (+6%), reaching total of 1.91 billion euros. Deposits from private customers increased by 9 million euros: demand deposits remained at the same level compared to the previous quarter and term deposits increased by 9 million euros. Deposits from domestic business customers increased by 24 million euros: demand deposits increased by 44 million euro and term deposits decreased by 20 million euros. Deposits from international deposit platform increased by 71 million euros and other financing increased by 40 million...

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter

Written by Customer Service on October 22, 2025. Posted in Earnings Releases And Operating Results.

Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while BioMaterials and Fine Chemicals had lower results compared with the 3rd quarter of 2024. The reduced EBITDA1 was due to lower bioethanol prices and the temporary disruption in cellulose production at the Sarpsborg site. The negative impact from this disruption amounts to approximately NOK 40 million. The improvement in the result for BioSolutions was attributable to sustained growth in sales to agriculture. In BioMaterials, higher sales prices were more than offset by lower sales volume. Fine chemical intermediates delivered a strong result. Net currency effects were positive across all areas. Profit before tax was NOK 247 million (NOK 326 million)....

Heineken N.V. reports on 2025 third quarter trading

Written by Customer Service on October 22, 2025. Posted in Earnings Releases And Operating Results.

Amsterdam, 22 October 2025 – Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announces Staying the course while navigating a challenging quarterKey Quarterly Highlights Revenue €8,712 million for the quarter, €25,636 million year to dateNet revenue (beia) organically down 0.3% for the quarter, up 1.3% year to dateBeer volume organically down 4.3% for the quarter, down 2.3% year to datePremium beer volume organically down 2.2% for the quarter, up 0.4% year to dateHeineken® volume down 0.6% for the quarter, up 2.7% year to date2025 organic operating profit (beia) growth anticipated to be towards the lower end of the 4% to 8% guidanceCEO Statement Dolf van den Brink, Chairman of the Executive Board / CEO, commented: “Macroeconomic volatility persisted as anticipated and became more pronounced in...

Novartis Cosentyx® meets primary and all secondary endpoints in Phase III trial in patients with polymyalgia rheumatica (PMR)

Written by Customer Service on October 22, 2025. Posted in Public Companies.

Cosentyx® (secukinumab) achieved statistically significant and clinically meaningful sustained remission vs placebo at Week 521Trial showed reduction in annual cumulative steroid dose vs placebo through Week 52; safety profile consistent with known profile of Cosentyx1Data highlight potential of Cosentyx as novel targeted PMR treatment, second most common inflammatory disease in adults ≥502, with limited options availableBasel, October 22, 2025 – Novartis today announced that Cosentyx® (secukinumab) met the primary endpoint and all secondary endpoints in the Phase III REPLENISH trial1. Cosentyx demonstrated statistically significant and clinically meaningful sustained remission vs placebo at Week 52 in adults with polymyalgia rheumatica (PMR)1. Data will be presented at an upcoming medical congress and submitted to health authorities...

EfTEN United Property Fund distributes approximately 420 000 euros to investors

Written by Customer Service on October 22, 2025. Posted in Dividend Reports And Estimates.

EfTEN Capital AS, as the management company of the EfTEN United Property Fund (stock market ticker EFCUPFFT, ISIN code EE3500001609) decided to make a cash distribution of 16,900 euro cents per unit, totalling 419 772 euros. The distribution constitutes approximately 2% of the fund’s latest closing price. This is the second distribution of the EfTEN United Property Fund in 2025 and together with the distribution in May, the fund has distributed over 9% of the market cap in 2025. Since the listing of EfTEN United Property Fund units on the Nasdaq Tallinn stock market in May 2022, the fund has made distributions in the amount of 1,4 euros per unit. The distribution is based on income from the EfTEN Real Estate Fund 5 and EfTEN Special Opportunities Fund as well as owner loan interests from the development company Invego Uus-Järveküla...

Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance

Written by Customer Service on October 22, 2025. Posted in Earnings Releases And Operating Results.

Year-to-date total sales growth of 12.1% at CER1, or 9.6% as reported, driven by all three therapeutic areas and including strong performance from Iqirvo®, Bylvay® and Somatuline® Further upgrade of full-year 2025 financial guidance based on slower than anticipated erosion of Somatuline® and accelerated sales growth of the rest of the portfolio: total sales growth of around 10.0%2 at CER (prior guidance greater than 7.0%); core operating margin of around 35.0% of total sales (prior guidance greater than 32.0%) Announcement today of the proposed acquisition of ImCheck Therapeutics bringing a first-in-class Phase II asset, expanding pipeline in oncologyPARIS, FRANCE, 22 October 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the year to date and the third...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals